Kaijun Zhao
Overview
Explore the profile of Kaijun Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Tan H, Dai J, Lin J, Zhao K, Hu H, et al.
J Adv Res
. 2025 Jan;
PMID: 39778768
Background: Cancer immunotherapy has emerged as a groundbreaking approach in cancer treatment, primarily realized through the manipulation of immune cells, notably T cell adoption and immune checkpoint blockade. Nevertheless, the...
2.
Lin J, Wang J, Zhao J, Wu X, Hao L, Tan X, et al.
Genes Dis
. 2024 Dec;
12(2):101346.
PMID: 39649846
No abstract available.
3.
Yang Y, Li J, Xiao Z, Yang X, Wang L, Duan Y, et al.
Neurosurg Rev
. 2024 Jul;
47(1):315.
PMID: 38992256
Previous research have demonstrated that the stress hyperglycemia ratio (SHR) accurately reflects acute hyperglycemic states and correlates with adverse outcomes. This study aims to explore the relationship between SHR and...
4.
Ma J, Liu Y, Zhao K
Dialogues Clin Neurosci
. 2024 Jun;
26(1):24-27.
PMID: 38829782
Introduction: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with a multifaceted etiology. This case report explores the ischemic cryptogenic vascular dissection as a potential underlying cause of ASD....
5.
Duan Z, Liang Y, Sun J, Zheng H, Lin T, Luo P, et al.
Innovation (Camb)
. 2024 Feb;
5(2):100564.
PMID: 38379787
The type V-I CRISPR-Cas system is becoming increasingly more attractive for genome editing. However, natural nucleases of this system often exhibit low efficiency, limiting their application. Here, we used structure-guided...
6.
Liu Y, Zhao S, Chen Y, Ma W, Lu S, He L, et al.
Cell Oncol (Dordr)
. 2023 Aug;
46(6):1791-1806.
PMID: 37646965
Purpose: Glioma has been demonstrated as one of the most malignant intracranial tumors and currently there is no effective treatment. Based on our previous RNA-sequencing data for oxidative phosphorylation (OXPHOS)-inhibition...
7.
Liu Y, Chen Y, Wang F, Lin J, Tan X, Chen C, et al.
Discov Oncol
. 2023 Aug;
14(1):161.
PMID: 37642765
Background: Glioma is a lethal brain cancer and lacking effective therapies. Challenges include no effective therapeutic target, intra- and intertumoral heterogeneity, inadequate effective drugs, and an immunosuppressive microenvironment, etc. Deciphering...
8.
Xu J, Wang C, Wang F, Liu Y, Li M, Wang H, et al.
Plant Biotechnol J
. 2023 Aug;
21(12):2525-2545.
PMID: 37578160
Plant leaf senescence, caused by multiple internal and environmental factors, has an important impact on agricultural production. The lectin receptor-like kinase (LecRLK) family members participate in plant development and responses...
9.
Shafique M, Guo W, Chen X, Zhao K, Liu Y, Wang C, et al.
Funct Integr Genomics
. 2023 May;
23(2):189.
PMID: 37246198
No abstract available.
10.
Duan G, Zhang Y, Yin H, Wu Y, Zhang X, Zhao R, et al.
Eur J Radiol
. 2023 Apr;
163:110833.
PMID: 37080061
Object: To assess the safety and efficacy of endovascular treatment (EVT) of unruptured middle cerebral artery (MCA) aneurysms in a retrospective cohort in a high-volume center. Predictors of complications and...